Financial reports
Current reports
6-K
PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
9 Apr 24
6-K
Current report (foreign)
19 Mar 24
6-K
Bristol Myers Squibb Completes Acquisition of PureTech’s Founded Entity Karuna Therapeutics for $14 Billion
18 Mar 24
6-K
Current report (foreign)
4 Mar 24
6-K
Current report (foreign)
5 Feb 24
6-K
Current report (foreign)
4 Jan 24
6-K
PureTech Year End Update and Outlook for 2024
20 Dec 23
6-K
Current report (foreign)
5 Dec 23
6-K
Current report (foreign)
2 Nov 23
6-K
Current report (foreign)
3 Oct 23
Registration and prospectus
SC TO-C
Information about tender offer
19 Mar 24
20FR12B/A
Initial registration of securities (foreign private issuers) (amended)
9 Nov 20
F-6
Registration for ADRs (foreign)
2 Nov 20
20FR12B
Initial registration of securities (foreign private issuers)
27 Oct 20
DRS
Draft registration statement
22 Sep 20
Proxies
No filings
Ownership
SC 13G/A
Invesco Ltd.
12 Feb 24
4
GELESIS HOLDINGS, INC.
21 Sep 23
4
GELESIS HOLDINGS, INC.
14 Jun 23
4
GELESIS HOLDINGS, INC.
31 May 23
4
GELESIS HOLDINGS, INC.
3 May 23
SC 13G/A
Invesco Ltd.
10 Feb 23
SC 13D
Akili, Inc.
30 Aug 22
3
Akili, Inc.
29 Aug 22
SC 13G/A
Invesco Ltd.
11 Feb 22
3
GELESIS HOLDINGS, INC.
21 Jan 22